John Reed on J&J’s R&D model, oncology deals and pipeline expansion potential

John Reed, J&J EVP, Innovative Medicine, R&D (Jordan Strauss/Invision/AP) June 29, 2026 01:51 PM EDTUpdated 02:24 PM R&DPharma John Reed on J&J’s R&D mod­el, re­cent on­col­o­gy deals and pipeline ex­pan­sion po­ten­tial Kyle LaHucik Biotech Correspondent John Reed has over­seen the pipelines of three of the largest drug­mak­ers since leav­ing South­ern Cal­i­for­nia’s San­ford Burn­ham med­ical re­search in­sti­tute 13 years ago, giv­ing … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER